Search

everythinglearnresearchcommunity

for

Search:↓

Ritlecitinib reduces alopecia areata symptoms by blocking JAK3/TEC signaling and T-cell activity.

AP-1 and TGFß work together to drive resistance in basal cell carcinoma, suggesting new treatment options.

A KLK5 inhibitor effectively improved skin symptoms in a mouse model of Netherton Syndrome.

Tofacitinib helps improve skin conditions in people with Down syndrome, especially alopecia areata.

Sacituzumab govitecan improves quality of life and extends life for breast cancer patients compared to standard chemotherapy.

Dabrafenib was effective and well tolerated in treating thyroid cancer with a specific mutation.

New mouse models of Pemphigus show severe symptoms and need better treatments.

An 8-year-old girl developed a rare skin condition in a linear pattern on one side of her body after a lung infection, which improved with treatment.

CDK4/6 inhibitors can protect hair cells from chemotherapy damage.

Vismodegib effectively treats advanced basal cell carcinoma but requires careful management of serious side effects.

The document concludes that ERBB2 mutations are common in extramammary Paget disease and may respond to systemic treatments like cancer immunotherapy.

Upadacitinib improved Crohn's disease, atopic dermatitis, and alopecia areata in one patient.

Temozolomide can cause severe bone marrow suppression, leading to life-threatening complications.

Carboplatin-paclitaxel is preferred for advanced lung cancer due to its balance of affordability and patient well-being.

Combining cetirizine and topical steroids can effectively manage severe lichen planus pilaris.

JAK inhibitors may help treat alopecia areata by reversing hair loss.

Tofacitinib helped a 19-year-old regrow hair after other treatments failed.

Baricitinib was effective in regrowing eyebrow and eyelash hair in patients with severe alopecia areata.

Targeted immunological therapies offer safer and more effective treatments for skin conditions like eczema and psoriasis.

Topical aprepitant reduces skin rash and hair loss caused by cancer treatment.

Tofacitinib helped an 8-year-old child recover from a type of hair loss that is hard to treat.

Suplatast tosilate successfully treated a woman's systemic sclerosis symptoms.

Vismodegib is effective for basal cell carcinoma but has severe side effects.

Tofacitinib helped a woman regrow her hair without relapses after other treatments failed.

CS12192 effectively treats alopecia areata with better safety than current options.

A patient with a nerve disorder died from infection complications after developing insulin resistance from a treatment.

Ruxolitinib may effectively treat APS-1 by reducing harmful immune responses.